Rhythm Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	54.3	89.14	60.08	127.68	59.25
Short-Term Investments	334.65	231.43	215.77	205.61	235.61
Cash & Short-Term Investments	388.95	320.57	275.85	333.29	294.86
Cash Growth	21.33%	16.21%	-17.23%	13.04%	70.64%
Accounts Receivable	26.08	18.51	14.87	6.22	1.03
Inventory	25.75	18.74	8.62	2.92	0.11
Other Current Assets	26.13	16.38	8.93	11.81	12.4
Total Current Assets	466.92	374.2	308.27	354.24	308.39
Net Property, Plant & Equipment	4.15	4.11	2.12	3.38	4.34
Other Intangible Assets	5.32	6.17	7.03	7.88	4.66
Other Long-Term Assets	3.81	7.79	15.33	16.98	12.14
Total Assets	480.2	392.27	332.75	382.48	329.52
Accounts Payable	13.95	12.33	4.89	4.8	5.74
Accrued Expenses	83.86	62.66	48.26	32.89	30.08
Current Portion of Leases	0.65	-	0.77	0.68	0.61
Unearned Revenue	0.19	1.29	1.29	1.43	7
Other Current Liabilities	7.3	39.25	-	-	-
Total Current Liabilities	105.94	115.52	55.2	39.81	43.43
Long-Term Leases	3.34	3.94	0.49	1.26	1.95
Other Long-Term Liabilities	100.89	108.27	107.29	77.15	-
Total Long-Term Liabilities	104.23	112.21	107.78	78.41	1.95
Total Liabilities	210.17	227.72	162.99	118.22	45.37
Common Stock	0.07	0.06	0.06	0.06	0.05
Additional Paid-in Capital	1,492	1,177	1,064	974.36	813.04
Accumulated Other Comprehensive Income	-0.8	-0.04	0.13	-0.09	-0
Retained Earnings	-1,352	-1,155	-894.74	-710.06	-528.94
Total Common Shareholders' Equity	139.07	21.73	169.76	264.26	284.15
Minority Interest	130.96	142.82	-	-	-
Shareholders' Equity	270.03	164.55	169.76	264.26	284.15
Total Liabilities & Equity	480.2	392.27	332.75	382.48	329.52
Total Debt	3.99	3.94	1.26	1.94	2.55
Net Cash (Debt)	384.96	316.63	274.59	331.34	292.3
Net Cash Growth	21.58%	15.31%	-17.13%	13.36%	72.24%
Net Cash Per Share	5.92	5.19	4.76	6.36	5.89
Book Value	139.07	21.73	169.76	264.26	284.15
Book Value Per Share	2.14	0.36	2.94	5.07	5.73
Tangible Book Value	133.75	15.56	162.73	256.38	279.49
Tangible Book Value Per Share	2.06	0.26	2.82	4.92	5.63

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q